獣医学本・書籍・ビデオ・雑誌・DVD・洋書　インターズーオンライン

■『偽妊娠』堀達也先生 著
1．Tsutsui,T., Kirihara,N., Hori,T. and Concannon,P.W. Plasma progesterone and prolactin concentrations in overtly pseudopregnant bitches: a clinical study. Theriogenology, 67:1032-1038, 2007.
2．Hori,T., Kawakami,E. and Tsutsui,T. Pituitary hormone responses to luteal regression after administration of prostaglandin F2alpha-analogue. Reprod. Domest.Anim., 39:298-302, 2004.
3．Harvey,M.J., Cauvin,A., Dale,M., Lindley,S., and Ballabio,R. Effect and mechanisms of the anti-prolactin drug cabergoline on pseudopregnancy in the bitch. J.Small Anim.Pract., 38:336-339, 1997.

■『人工流産』堀達也先生 著
1．Goericke-Pesch,S., Georgiev,P., Wehrend,A. Prevention of pregnancy in cats using aglepristone on days 5 and 6 after mating. Theriogenology. 74:304-310, 2010.
2．Kirihara,N., Naganawa,A., Hori,T., Kawakami,E., Tsutsui,T. Influence of a PGF2alpha-analogue, etiproston tromethamine, on the functional corpus luteum of dogs. J.Vet.Med.Sci. 67:1-6, 2005.
3．Hori,T., Akikawa,T., Kawakami,E., Tsutsui,T. Fenprostalene-induced abortion in bitches. J.Vet.Med.Sci. 64:993-998, 2002.
4．Tsutsui,T., Mizutani,W., Hori,T., Oishi,K., Sugi,Y., Kawakami,E. Estradiol benzoate for preventing pregnancy in mismated dogs. Theriogenology. 66:1568-1572, 2006.
5．Georgiev,P., Wehrend,A. Mid-gestation pregnancy termination by the progesterone antagonist aglepristone in queens. Theriogenology. 65:1401-1406, 2006.
6．Eilts,B.E. Pregnancy termination in the bitch and queen. Clin.Tech.Small Anim.Pract. 17:116-123, 2002.

■『猫の胆管炎』鳥巣至道先生 著
1．Weiss DJ, Gagne JM, Armstrong PJ: Relationship between inflammatory hepatic disease and inflammatory bowel disease, pancreatitis, and nephritis in cats. J Am Vet Med Assoc. Sep 15;209(6):1114-6. (1996)
2．Gary D. Norsworthy, Mitchell A. Crystal, Sharon Fooshee Grace, Larry P. Tilley: The Feline Patient, Third Edition, 125-127, 312-313, Blackwell Publishing, UK (2006)
3．Richard W. Nelson, C.Guillermo Couto （長谷川篤彦, 辻本元 監訳）:猫の胆道系疾患、スモールアニマル・インターナルメディスン　第3版（日本語版）、529-541、インターズー、東京（2005）
4．WSAVA Liver Standardization Group: Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases, SAUNDERS ELSEVIER, USA (2006)
5．Edwards DF, McCracken MD, Richardson DC: Sclerosing cholangitis in a cat. J Am Vet Med Assoc. Apr 1;182(7):710-2.(1983)
6．Gagne JM, Armstrong PJ, Weiss DJ, Lund EM, Feeney DA, King VL: Clinical features of inflammatory liver disease in cats: 41 cases (1983-1993). J Am Vet Med Assoc. Feb 15;214(4):513-6.(1999)

■『眼底の疾患』小林義崇先生 著
1. Andrew SE, Abrams KL, Brooks DE KP. Clinical features of steroid responsive retinal detachments in twenty-two dogs. Vet & Comp Ophthalmol. 1997;7:82-7.
2. Brown S, Atkins C, Bagley R, et al. Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine. 2007;21(3):542-58.
3. Crispin SM, Mould JR. Systemic hypertensive disease and the feline fundus. Veterinary ophthalmology. 2001;4(2):131-40.
4. Gelatt KN. Veterinary ophthalmology, Volume 2. Blackwell Pub.; 2007.
5. Grahn BH, Barnes LD, Breaux CB, Sandmeyer LS. Chronic retinal detachment and giant retinal tears in 34 dogs: outcome comparison of no treatment, topical medical therapy, and retinal reattachment after vitrectomy. The Canadian veterinary journal. La revue veterinaire canadienne. 2007;48(10):1031-9.
6. Grahn BH, Sandmeyer LS. Bilateral rhegmatogenous retinal detachments with giant retinal tears. The Canadian veterinary journal. La revue veterinaire canadienne. 2009;50(9):989-90.
7. Grozdanic SD, Harper MM, Kecova H. Antibody-mediated retinopathies in canine patients: mechanism, diagnosis, and treatment modalities. The Veterinary clinics of North America. Small animal practice. 2008;38(2):361-87, vii.
8. Grozdanic SD, Matic M, Sakaguchi DS, Kardon RH. Evaluation of retinal status using chromatic pupil light reflex activity in healthy and diseased canine eyes. Investigative ophthalmology & visual science. 2007;48(11):5178-83.
9. Gwin RM, Wyman M, Ketring K, Winston S. Idiopathic uveitis and exudative retinal detachment in the dog. Journal of the American Animal Hospital Association. 1980;16(2):163-170.
10. Keller RL, Kania S a, Hendrix DVH, Ward D a, Abrams K. Evaluation of canine serum for the presence of antiretinal autoantibodies in sudden acquired retinal degeneration syndrome. Veterinary ophthalmology. 2006;9(3):195-200.
11. Komaromy AM, Andrew SE, Denis HM, Brooks DE, Gelatt KN. Hypertensive retinopathy and choroidopathy in a cat. Veterinary ophthalmology. 2004;7(1):3-9.
12. Ledbetter EC, Landry MP, Stokol T, Kern TJ, Messick JB. Brucella canis endophthalmitis in 3 dogs: clinical features, diagnosis, and treatment. Veterinary ophthalmology. 2009;12(3):183-91.
13. Maggio F, DeFrancesco TC, Atkins CE, et al. Ocular lesions associated with systemic hypertension in cats: 69 cases (1985-1998). Journal of the American Veterinary Medical Association. 2000;217(5):695-702.
14. Maggs DJ, Miller PE, Ofri R, Slatter DH. Slatter's fundamentals of veterinary ophthalmology. Elsevier Health Sciences; 2008.
15. Montgomery KW, Der Woerdt A van, Cottrill NB. Acute blindness in dogs: sudden acquired retinal degeneration syndrome versus neurological disease (140 cases, 2000-2006). Veterinary ophthalmology. 2008;11(5):314-20.
16. Pizzirani S, Davidson MG, Gilger BC. Transpupillary diode laser retinopexy in dogs: ophthalmoscopic, fluorescein angiographic and histopathologic study. Veterinary ophthalmology. 2003;6(3):227-35.
17. Schmidt GM, Vainisi SJ. Retrospective study of prophylactic random transscleral retinopexy in the Bichon Frise with cataract. Veterinary ophthalmology. 2004;7(5):307-10.
18. Stades FC, Wyman M, Boeve MH, Neumann W, Spiess B. Ophthalmology for the veterinary practitioner. Wiley-Blackwell; 2007.
19. Subhadra C, Dudek AZ, Rath PP, Lee MS. Improvement in visual fields in a patient with melanoma-associated retinopathy treated with intravenous immunoglobulin. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2008;28(1):23-6.
20. Watanabe T, Mishina M. Effects of benazepril hydrochloride in cats with experimentally induced or spontaneously occurring chronic renal failure. The Journal of veterinary medical science / the Japanese Society of Veterinary Science. 2007;69(10):1015-23.
21. Wolfer J, Grahn B, Arrington K. Diagnostic ophthalmology. Bilateral, bullous retinal detachment. The Canadian veterinary journal. La revue veterinaire canadienne. 1998;39(1):57-8.

■『感染性心内膜炎』藤井洋子先生 著
1.Sykes JE, Kittleson MD, Pesavento PA, et al. Evaluation of the relationship between causative organisms and clinical characteristics of infective endocarditis in dogs: 71 cases (1992-2005). J Am Vet Med Assoc 2006;228:1723-1734.
2.Macdonald K. Infective endocarditis in dogs: diagnosis and therapy. Vet Clin North Am Small Anim Pract;40:665-684.
3.Sisson D, Thomas WP. Endocarditis of the aortic valve in the dog. J Am Vet Med Assoc 1984;184:570-577.
4.Peddle GD, Drobatz KJ, Harvey CE, et al. Association of periodontal disease, oral procedures, and other clinical findings with bacterial endocarditis in dogs. J Am Vet Med Assoc 2009;234:100-107.
5.MacDonald KA, Chomel BB, Kittleson MD, et al. A prospective study of canine infective endocarditis in northern California (1999-2001): emergence of Bartonella as a prevalent etiologic agent. J Vet Intern Med 2004;18:56-64.
6.Peddle GD, Boger L, Van Winkle TJ, et al. Gerbode type defect and third degree atrioventricular block in association with bacterial endocarditis in a dog. J Vet Cardiol 2008;10:133-139.
7.Quintavalla C, Mavropoulou A, Buratti E. Aortic endocarditis associated with a perforated septal membranous aneurysm in a boxer dog. J Small Anim Pract 2007;48:330-334.
8.Arai S, Wright BD, Miyake Y, et al. Heterotopic implantation of a porcine bioprosthetic heart valve in a dog with aortic valve endocarditis. J Am Vet Med Assoc 2007;231:727-730.
9.Sykes JE, Kittleson MD, Chomel BB, et al. Clinicopathologic findings and outcome in dogs with infective endocarditis: 71 cases (1992-2005). J Am Vet Med Assoc 2006;228:1735-1747.

■『三尖弁閉鎖不全症』藤井洋子先生 著
1.Sisson D KC, Darke PGG. Acquired valvular heart disease in dogs and cats. In: Fox PR SD, Moise NS., ed. Textbook of canine and feline cardiology. Philadelphia: WB Saunders, 1999;555-556.
2.Serres FJ, Chetboul V, Tissier R, et al. Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001-2005). J Am Vet Med Assoc 2006;229:1772-1778.
3.Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-231.
4.Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-268.
5.Andelfinger G, Wright KN, Lee HS, et al. Canine tricuspid valve malformation, a model of human Ebstein anomaly, maps to dog chromosome 9. J Med Genet 2003;40:320-324.
6.Shiran A, Sagie A. Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol 2009;53:401-408.

■『僧帽弁閉鎖不全症』藤井洋子先生 著
1.Atkins C, Bonagura J, Ettinger S, et al. Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med 2009;23:1142-1150.
2.Beardow AW, Buchanan JW. Chronic mitral valve disease in cavalier King Charles spaniels: 95 cases (1987-1991). J Am Vet Med Assoc 1993;203:1023-1029.
3.Pedersen HD, Kristensen BO, Lorentzen KA, et al. Mitral valve prolapse in 3-year-old healthy Cavalier King Charles Spaniels. An echocardiographic study. Can J Vet Res 1995;59:294-298.
4.Oyama MA, Levy RJ. Insights into serotonin signaling mechanisms associated with canine degenerative mitral valve disease. J Vet Intern Med;24:27-36.
5.Rush JE, Lee ND, Freeman LM, et al. C-reactive protein concentration in dogs with chronic valvular disease. J Vet Intern Med 2006;20:635-639.
6.Dell'italia LJ, Balcells E, Meng QC, et al. Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs. Am J Physiol 1997;273:H961-970.
7.Schultz D, Su X, Bishop SP, et al. Selective induction of the creatine kinase-B gene in chronic volume overload hypertrophy is not affected by ACE-inhibitor therapy. J Mol Cell Cardiol 1997;29:2665-2673.
8.Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group. The COVE Study Group. J Vet Intern Med 1995;9:243-252.
9.Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study. The IMPROVE Study Group. J Vet Intern Med 1995;9:234-242.
10.Ettinger SJ, Benitz AM, Ericsson GF, et al. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. J Am Vet Med Assoc 1998;213:1573-1577.
11.Fujii Y, Wakao Y. Spectral analysis of heart rate variability in dogs with mild mitral regurgitation. Am J Vet Res 2003;64:145-148.
12.Fujii Y, Orito K, Muto M, et al. Modulation of the tissue reninangiotensin-aldosterone system in dogs with chronic mild regurgitation through the mitral valve. Am J Vet Res 2007;68:1045-1050.
13.Kvart C, Haggstrom J, Pedersen HD, et al. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation. J Vet Intern Med 2002;16:80-88.
14.Atkins CE, Keene BW, Brown WA, et al. Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency. J Am Vet Med Assoc 2007;231:1061-1069.
15.Marcondes-Santos M, Tarasoutchi F, Mansur AP, et al. Effects of carvedilol treatment in dogs with chronic mitral valvular disease. J Vet Intern Med 2007;21:996-1001.
16.Adin DB, Taylor AW, Hill RC, et al. Intermittent bolus injection versus continuous infusion of furosemide in normal adult greyhound dogs. J Vet Intern Med 2003;17:632-636.
17.Hori Y, Katou A, Tsubaki M, et al. Assessment of diuretic effects and changes in plasma aldosterone concentration following oral administration of a single dose of furosemide or azosemide in healthy dogs. Am J Vet Res 2008;69:1664-1669.
18.Rationale and design of a randomized trial to assess the effects of diuretics in heart failure: Japanese Multicenter Evaluation of Long- vs Short-Acting Diuretics in Congestive Heart Failure (J-MELODIC). Circ J 2007;71:1137-1140.
19.Lombard CW, Jons O, Bussadori CM. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. J Am Anim Hosp Assoc 2006;42:249-261.
20.Haggstrom J, Boswood A, O'Grady M, et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet Intern Med 2008;22:1124-1135.
21.Chetboul V, Lefebvre HP, Sampedrano CC, et al. Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease: a prospective, controlled, blinded, and randomized study. J Vet Intern Med 2007;21:742-753.
22.Tissier R, Chetboul V, Moraillon R, et al. Increased mitral valve regurgitation and myocardial hypertrophy in two dogs with long-term pimobendan therapy. Cardiovasc Toxicol 2005;5:43-51.
23.Ouellet M, Belanger MC, Difruscia R, et al. Effect of pimobendan on echocardiographic values in dogs with asymptomatic mitral valve disease. J Vet Intern Med 2009;23:258-263.
24.Bernay F, Bland JM, Haggstrom J, et al. Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease. J Vet Intern Med;24:331-341.
25.Gelzer AR, Kraus MS, Rishniw M, et al. Combination therapy with digoxin and diltiazem controls ventricular rate in chronic atrial fibrillation in dogs better than digoxin or diltiazem monotherapy: a randomized crossover study in 18 dogs. J Vet Intern Med 2009;23:499-508.
26.Serres FJ, Chetboul V, Tissier R, et al. Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001-2005). J Am Vet Med Assoc 2006;229:1772-1778.
27.Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-231.
28.Hochreiter C, Niles N, Devereux RB, et al. Mitral regurgitation: relationship of noninvasive descriptors of right and left ventricular performance to clinical and hemodynamic findings and to prognosis in medically and surgically treated patients. Circulation 1986;73:900-912.
29.Adin DB, Kittleson MD, Hornof WJ, et al. Efficacy of a single oral dose of isorsorbide 5-mononitrate in normal dogs and in dogs with congestive heart failure. J Vet Intern Med 2001;15:105-111.

■『表在性膿皮症』岩崎利郎先生 著
1.van Damme CMM, Willemse T, van Dijk A, Haagsman HP, Veldhuizen EJA. 2009. Altered cutaneous expression of b-defensin in dogs with atopic dermatitis. Mol. Immunol. 46: 2449-2455.
2.Leofeler A, Linek m, Moodley A, Guardbassei L, Sung JM, Winkler M, Weiss R, Lloyd DH. 2007. First report of multi-resistant, mec A-positive Staphylococcus intermedius in Europe: 12 cases from a veterinary dermatology referral clinic in Germany. Vet. Dermatol. 18:412-421.
3.Sasaki T, Kikuchi K, Tanaka Y, Takahashi N, Kamata S, Hiramatsu K. 2007. Reclassification of phenotypically identified Staphylococcus intermedius strain. J. Clin. Microbiol. 45: 2770-2778.
4.Devriese LA, Hermans K, Baele M, Haesebrouck F. 2009. Staphylococcus pseudintermedius versus Staphylococcus intermedius. Vet. Microbiol. 133: 206-207.
5. Griggeth GC, Morris DO, Abraham JL, Shofer FS, Rankin SC. 2008. Screening for skin carriage of methicillin-resistant coagulase-positive staphylococci and Staphylococcus schliferi in dogs with healthy and inflamed skin. Vet Dermatol. 19: 142-149.

■『肉芽腫性脂腺炎』岩崎利郎先生 著
1.Reichter IM, Hauser B, Schiller I, Dunstan RW, Credille KM, Binder H, Glaus T, Arnold S. Sebaceous adenitis in the Akita: clinical observations, histopathology and heredity. 2001, Vet. Dermatol. 12: 243-253.
2.Gross TL, Ihrke PJ, Walder EJ, Affolter VK. Sebaceous adenitis. Skin Diseases of the Dog and Cat. Clinical and Histopathologic Diagnosis, 2nd ed. Oxford, Blackwell, 2005, 453-457..
3.White SD, Rosychuk RA, Scott KV, Hargis AM, Jonas L, Trettien A. Sebaceous adenitis in dogs and results of treatment with isotretinoin and etretinate: 30 cases (1990-1994). 1995, J. Am Vet. Med. Assic. 207: 197-200.
4.Carothers MA, Kwochka KW, Rojko JL. Cyclosporine responsive granulomatous sebaceous adenitis in a dog. 1991, J. Am. Vet. Med. Assoc. 198: 1645-1648.
5.Linek M, Boss C, Haemmerling R, Hewicker-Traurwein M, Mecklenburg L. Effects of cyclosporine A on clinical and histologic abnormalities in dogs with sebaceous adenitis. 2005, J. Am. Vet. Med. Assoc. 226: 59-64.

■『好酸球性肉芽腫群』関口麻衣子先生 著
1.Scott DW, Miller WH, Griffin CE. Muller & Kirk's Small Animal Dermatology. 6th ed. Philadelphia,W.B. Saunders; 2001.
2.Gross TL, IHRKE PJ, Walder EJ, Affolter VK. Skin Disease of The Dog and Cat. 2nd ed. Oxford,Blackwell Sience;2005.
3.岩崎利郎監訳．カラーハンドブック 犬と猫の皮膚病，メディカルサイエンス社，東京，2001．
4.Medleau L, Hnilica KA. Small Animal Dermatology. A Color Altas and Therapeutic Guide. 2nd ed. Missouri, Saunders Elsevier; 2006.

■『猫の心因性脱毛』関口麻衣子先生 著
1.Scott DW, Miller WH, Griffin CE. Muller & Kirk's Small Animal Dermatology. 6th ed. Philadelphia,W.B. Saunders; 2001.
2.Gross TL, IHRKE PJ, Walder EJ, Affolter VK. Skin Disease of The Dog and Cat. 2nd ed. Oxford,Blackwell Sience;2005.
3.桃井康行，小動物の治療薬，文永堂出版，東京，2006．

■『犬のブドウ膜皮膚症候群』関口麻衣子先生 著
1.Scott DW, Miller WH, Griffin CE. Muller & Kirk's Small Animal Dermatology. 6th ed. Philadelphia,W.B. Saunders; 2001.
2.Gross TL, IHRKE PJ, Walder EJ, Affolter VK. Skin Disease of The Dog and Cat. 2nd ed. Oxford,Blackwell Sience;2005.
3.岩崎利郎監訳．カラーハンドブック 犬と猫の皮膚病，メディカルサイエンス社，東京，2001．
4.清水宏著．あたらしい皮膚科学，中山書房，東京，2005．
5.Medleau L, Hnilica KA. Small Animal Dermatology. A Color Altas and Therapeutic Guide. 2nd ed. Missouri, Saunders Elsevier; 2006

■『心肺停止』藤井洋子先生 著
1.Evans AT. New thoughts on cardiopulmonary resuscitation. Vet Clin North Am Small Anim Pract 1999;29:819-829, viii.
2.Hofmeister EH, Brainard BM, Egger CM, et al. Prognostic indicators for dogs and cats with cardiopulmonary arrest treated by cardiopulmonary cerebral resuscitation at a university teaching hospital. J Am Vet Med Assoc 2009;235:50-57.
3.Safar P. Long-term animal outcome models for cardiopulmonary-cerebral resuscitation research. Crit Care Med 1985;13:936-940.
4.Tisherman SA, Safar P, Radovsky A, et al. Therapeutic deep hypothermic circulatory arrest in dogs: a resuscitation modality for hemorrhagic shock with 'irreparable' injury. J Trauma 1990;30:836-847.
5.2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2005;112:IV1-203.
6.Chandra NC, Gruben KG, Tsitlik JE, et al. Observations of ventilation during resuscitation in a canine model. Circulation 1994;90:3070-3075.
7.Liu Y, Rosenthal RE, Haywood Y, et al. Normoxic ventilation after cardiac arrest reduces oxidation of brain lipids and improves neurological outcome. Stroke 1998;29:1679-1686.
8.Aufderheide TP, Lurie KG. Death by hyperventilation: a common and life-threatening problem during cardiopulmonary resuscitation. Crit Care Med 2004;32:S345-351.
9.Fewell JE, Abendschein DR, Carlson CJ, et al. Continuous positive-pressure ventilation decreases right and left ventricular end-diastolic volumes in the dog. Circ Res 1980;46:125-132.
10.Seed RF, Sykes MK, Finlay WE. The effect of variations in end-expiratory inflation pressure on cardiorespiratory function before and after open-heart surgery. Br J Anaesth 1970;42:488-496.
11.Fitzgerald KR, Babbs CF, Frissora HA, et al. Cardiac output during cardiopulmonary resuscitation at various compression rates and durations. Am J Physiol 1981;241:H442-448.
12.Ohomoto T, Miura I, Konno S. A new method of external cardiac massage to improve diastolic augmentation and prolong survival time. Ann Thorac Surg 1976;21:284-290.
13.Bartlett RL, Stewart NJ, Jr., Raymond J, et al. Comparative study of three methods of resuscitation: closed-chest, open-chest manual, and direct mechanical ventricular assistance. Ann Emerg Med 1984;13:773-777.
14.Kern KB, Sanders AB, Badylak SF, et al. Long-term survival with open-chest cardiac massage after ineffective closed-chest compression in a canine preparation. Circulation 1987;75:498-503.
15.Sanders AB, Kern KB, Ewy GA, et al. Improved resuscitation from cardiac arrest with open-chest massage. Ann Emerg Med 1984;13:672-675.
16.Manning JE, Murphy CA, Jr., Batson DN, et al. Aortic arch versus central venous epinephrine during CPR. Ann Emerg Med 1993;22:703-708.
17.Guyette FX, Guimond GE, Hostler D, et al. Vasopressin administered with epinephrine is associated with a return of a pulse in out-of-hospital cardiac arrest. Resuscitation 2004;63:277-282.
18.Wenzel V, Lindner KH, Prengel AW, et al. Endobronchial vasopressin improves survival during cardiopulmonary resuscitation in pigs. Anesthesiology 1997;86:1375-1381.
19.Lindner KH, Prengel AW, Pfenninger EG, et al. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation 1995;91:215-221.
20.Prengel AW, Lindner KH, Keller A. Cerebral oxygenation during cardiopulmonary resuscitation with epinephrine and vasopressin in pigs. Stroke 1996;27:1241-1248.
21.Schmittinger CA, Astner S, Astner L, et al. Cardiopulmonary resuscitation with vasopressin in a dog. Vet Anaesth Analg 2005;32:112-114.
22.Yakaitis RW, Ewy GA, Otto CW, et al. Influence of time and therapy on ventricular defibrillation in dogs. Crit Care Med 1980;8:157-163.
23.Rao AC, Naeem N, John C, et al. Direct current cardioversion does not cause cardiac damage: evidence from cardiac troponin T estimation. Heart 1998;80:229-230.
24.Verdejo Paris J, Muggenburg MC, Cardenas Loaeza M, et al. [Myocardial damage following cardioversion]. Arch Inst Cardiol Mex 1981;51:361-364.
25.Plunkett SJ, McMichael M. Cardiopulmonary resuscitation in small animal medicine: an update. J Vet Intern Med 2008;22:9-25.